Search research articles
Contact Us
Filters
Showing results (381-390 of 593) with videos related to
Page
of 60
Sort By:
Journal of Molecular Biology
|
August 6, 2010
Crystal Structure of the 2-Oxoglutarate- and Fe(II)-Dependent Lysyl Hydroxylase JMJD6
Monica Mantri, Tobias Krojer, Eleanor A Bagg, et al.
Antimicrobial Agents and Chemotherapy
|
December 16, 2015
Comparison of Verona Integron-Borne Metallo-β-Lactamase (VIM) Variants Reveals Differences in Stability and Inhibition Profiles
Anne Makena, Azer Ö Düzgün, Jürgen Brem, et al.
The Journal of Antimicrobial Chemotherapy
|
October 18, 2014
Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability
Anne Makena, Jürgen Brem, Inga Pfeffer, et al.
Journal of Medicinal Chemistry
|
January 31, 2024
Focused Screening Identifies Different Sensitivities of Human TET Oxygenases to the Oncometabolite 2-Hydroxyglutarate
Roman Belle, Hilal Saraç, Eidarus Salah, et al.
Chemical Science
|
April 29, 2017
NMR-filtered virtual screening leads to non-metal chelating metallo-β-lactamase inhibitors
Guo-Bo Li, Martine I Abboud, Jürgen Brem, et al.
Cell Reports. Physical Science
|
September 18, 2025
Revealing the catalytic mechanism of the Fe(II)/2-oxoglutarate-dependent human epigenetic modifying enzyme ALKBH5
Fathima Hameed Cherilakkudy, Midhun George Thomas, Ann Varghese, et al.
The Journal of Biological Chemistry
|
December 1, 2006
Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates
Kirsty S Hewitson, Benoit M R Liénard, Michael A McDonough, et al.
Iscience
|
November 7, 2022
Activity-based probes trap early active intermediates during metacaspase activation
Vida Štrancar, Katarina P van Midden, Daniel Krahn, et al.
Kidney International
|
May 17, 2017
Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor
Serafim Kiriakidis, Simon S Hoer, Natalie Burrows, et al.
Journal of Molecular Biology
|
May 24, 2011
Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1)
Rasheduzzaman Chowdhury, Emily Flashman, Jasmin Mecinović, et al.
Page
of 60
Search research articles
Search
Showing results (381-390 of 593) with videos related to
Sort By:
Page
of 60
Journal of Molecular Biology
|
August 6, 2010
Crystal Structure of the 2-Oxoglutarate- and Fe(II)-Dependent Lysyl Hydroxylase JMJD6
Monica Mantri, Tobias Krojer, Eleanor A Bagg, et al.
Antimicrobial Agents and Chemotherapy
|
December 16, 2015
Comparison of Verona Integron-Borne Metallo-β-Lactamase (VIM) Variants Reveals Differences in Stability and Inhibition Profiles
Anne Makena, Azer Ö Düzgün, Jürgen Brem, et al.
The Journal of Antimicrobial Chemotherapy
|
October 18, 2014
Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability
Anne Makena, Jürgen Brem, Inga Pfeffer, et al.
Journal of Medicinal Chemistry
|
January 31, 2024
Focused Screening Identifies Different Sensitivities of Human TET Oxygenases to the Oncometabolite 2-Hydroxyglutarate
Roman Belle, Hilal Saraç, Eidarus Salah, et al.
Chemical Science
|
April 29, 2017
NMR-filtered virtual screening leads to non-metal chelating metallo-β-lactamase inhibitors
Guo-Bo Li, Martine I Abboud, Jürgen Brem, et al.
Cell Reports. Physical Science
|
September 18, 2025
Revealing the catalytic mechanism of the Fe(II)/2-oxoglutarate-dependent human epigenetic modifying enzyme ALKBH5
Fathima Hameed Cherilakkudy, Midhun George Thomas, Ann Varghese, et al.
The Journal of Biological Chemistry
|
December 1, 2006
Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates
Kirsty S Hewitson, Benoit M R Liénard, Michael A McDonough, et al.
Iscience
|
November 7, 2022
Activity-based probes trap early active intermediates during metacaspase activation
Vida Štrancar, Katarina P van Midden, Daniel Krahn, et al.
Kidney International
|
May 17, 2017
Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor
Serafim Kiriakidis, Simon S Hoer, Natalie Burrows, et al.
Journal of Molecular Biology
|
May 24, 2011
Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1)
Rasheduzzaman Chowdhury, Emily Flashman, Jasmin Mecinović, et al.
Page
of 60